近日，成都市政府办公厅发布《成都市促进生物医药产业高质量发展若干政策措施》（下称《政策》），从支持药械研发创新、提高临床研究质效、支持产品临床应用、支持企业发展壮大、构建完善产业生态五个方面提出了25条政策措施，推动产业发展。对首次取得医疗器械注册证、具有自主知识产权的第三类医疗器械，《政策》表示按研发投入的20%给予最高500万元奖励，纳入国家创新医疗器械特别审批或优先审批程序的，最高奖励金额再提高100万元，单个企业每年最高奖励1000万元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.